German skin cancer patients join the EPIC-Skin study

Corporate Breaking News

Home : German skin cancer patients join the EPIC-Skin study

Jul 28 2022	German skin cancer patients join the EPIC-Skin study
ROSTOCK, Germany, July 28, 2022 /PRNewswire/ -- OncoBeta® GmbH has announced University Clinic of Rostock is participating in the global phase IV EPIC-Skin Study (Efficacy of Personalised Irradiation with Rhenium-SCT – for the treatment of non-melanoma skin cancer [NMSC]) treating its...


Source:https://www.prnewswire.com:443/news-releases/german-skin-cancer-patients-join-the-epic-skin-study-301594983.html

Related News
» K-12 Blended E-Learning Market, Growing number of affordable online courses to Boost Market Growth, Market Segmentation by Product and Geography- Technavio » Explainable AI: How to Build Next-Gen AI Models That You Can Trust \| Webinar by Quantzig